GAD67 and GAD65 mRNA and Protein Expression in Cerebrocortical Regions of Elderly Patients with Schizophrenia

Journal of Neuroscience Research

Volumn 76, Issue 4, 2004, Pages 581-592

  Dracheva, Stella ^a,b   Elhakem, Sharif L ^a   McGurk, Susan R ^a   Davis, Kenneth L ^a,b   Haroutunian, Vahram ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Dorsolateral prefrontal cortex; GAD; GAD65; GAD67; Gene expression; Glutamic acid decarboxylase; Molecular beacons; Real time RT PCR; RNA; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID; CARRIER PROTEIN; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; ISOENZYME; MESSENGER RNA; PROTEIN GAT 1; UNCLASSIFIED DRUG;

AGED; ARTICLE; BRAIN CORTEX; BRAIN REGION; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; ELDERLY CARE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MALE; MOLECULAR WEIGHT; NEUROTRANSMISSION; NUCLEOTIDE SEQUENCE; OCCIPITAL CORTEX; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHIZOPHRENIA;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ANIMALS; ANTIPSYCHOTIC AGENTS; CARRIER PROTEINS; CASE-CONTROL STUDIES; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GABA PLASMA MEMBRANE TRANSPORT PROTEINS; GENE EXPRESSION REGULATION; GLUTAMATE DECARBOXYLASE; HUMANS; IMMUNOBLOTTING; ISOENZYMES; MALE; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; ORGANIC ANION TRANSPORTERS; POSTMORTEM CHANGES; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCHIZOPHRENIA; TIME FACTORS;

EID: 2342471419     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20122     Document Type: Article

References (66)

1. Abe S, Suzuki T, Ito T, Baba A, Hori T, Kurita H, Yamaguchi M, Shiraishi H. 2000. Differential expression of GABA(A) receptor subunit mRNAs and ligand binding sites in rat brain following phencyclidine administration. Synapse 38:51-60.
2. A receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls. Cereb Cortex 5:550-560.
3. Akbarian S, Kim J, Potkin S, Hagman J, Tafazzoli A, Bunney W, Jones E. 1995b. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 52:258-266.
4. Benes FM. 2000. Emerging principles of altered neural circuitry in schizophrenia. Brain Res Brain Res Rev 31:251-269.
5. A receptor binding in the hippocampal formation of schizophrenic brain. Synapse 22:338-349.
6. Berman KF, Illowsky BP, Weinberger DR. 1988. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. IV. Further evidence for regional and behavioral specificity. Arch Gen Psychiatry 45:616-622.
7. Bird ED, Spokes EGS, Barnes J, Mackay AVP, Iversen LL, Shepherd M. 1978. Glutamic acid decarboxylase in schizophrenia. Lancet 1:156-159.
8. Bonnet G, Tyagi S, Libchaber A, Kramer FR. 1999. Thermodynamic basis of the enhanced specificity of structured DNA probes. Proc Natl Acad Sci USA 96:6171-6176.
9. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
10. Branchereau P, Van Bockstaele EJ, Chan J, Pickel VM. 1996. Pyramidal neurons in rat prefrontal cortex show a complex synaptic response to single electrical stimulation of the locus coeruleus region: evidence for antidromic activation and GABAergic inhibition using in vivo intracellular recording and electron microscopy. Synapse 22:313-331.
11. Bunney WE, Bunney BG. 2000. Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia. Brain Res Brain Res Rev 31:138-146.
12. Burnet PW, Eastwood SL, Harrison PJ. 1996. 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia. Neuropsychopharmacology 15:442-455.
13. Carlsson A, Waters N, Holm-Waters S, Tedroff J, Nilsson M, Carlsson ML. 2001. Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu Rev Pharmacol Toxicol 41:237-260.
14. Carr DB, Sesack SR. 2000. GABA-containing neurons in the rat ventral tegmental area project to the prefrontal cortex. Synapse 38:114-123.
15. Casanova MF, Goldberg TE, Suddath RL, Daniel DG, Rawlings R, Lloyd DG, Loats HL, Kleinman JE, Weinberger DR. 1990. Quantitative shape analysis of the temporal and prefrontal lobes of schizophrenic patients: a magnetic resonance image study. J Neuropsychiatry Clin Neurosci 2:363-372.
16. Chang YC, Gottlieb DI. 1988. Characterization of the proteins purified with monoclonal antibodies to glutamic acid decarboxylase. J Neurosci 8:2123-2130.
17. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
18. Conti F, Melone M, De Biasi S, Minelli A, Brecha NC, Ducati A. 1998. Neuronal and glial localization of GAT-1, a high-affinity gamma- aminobutyric acid plasma membrane transporter, in human cerebral cortex: with a note on its distribution in monkey cortex. J Comp Neurol 396:51-63.
19. Davidson M, Harvey PD, Powchik P, Parrella M, White L, Knobler HY, Losonczy MF, Keefe RS, Katz S, Frecska E. 1995. Severity of symptoms in chronically institutionalized geriatric schizophrenic patients. Am J Psychiatry 152:197-207.
20. Davis KL, Mohs RC, Marin DB, Purohit DP, Perl DP, Lantz M, Austin G, Haroutunian V. 1999. Cholinergic markers are not decreased in early Alzheimer's disease. JAMA 281:1401-1406.
21. Daviss SR, Lewis DA. 1995. Local circuit neurons of the prefrontal cortex in schizophrenia: selective increase in the density of calbindin-immunoreactive neurons. Psychiatry Res 59:81-96.
22. Dirkx R Jr, Thomas A, Li L, Lernmark A, Sherwin RS, De Camilli P, Solimena M. 1995. Targeting of the 67-kDa isoform of glutamic acid decarboxylase to intracellular organelles is mediated by its interaction with the NH2-terminal region of the 65-kDa isoform of glutamic acid decarboxylase. J Biol Chem 270:2241-2246.
23. Dracheva S, Marras SAE, Kramer FR, Davis KL, Haroutunian V. 2001. N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia. Am J Psychiatry 158:1400-1410.
24. Durkin MM, Smith KE, Borden LA, Weinshank RL, Branchek TA, Gustafson EL. 1995. Localization of messenger RNAs encoding three GABA transporters in rat brain: an in situ hybridization study. Brain Res Mol Brain Res 33:7-21.
25. Erlander MG, Tillakaratne NJ, Feldblum S, Patel N, Tobin AJ. 1991. Two genes encode distinct glutamate decarboxylases. Neuron 7:91-100.
26. Esclapez M, Tillakaratne NJ, Tobin AJ, Houser CR. 1993. Comparative localization of mRNAs encoding two forms of glutamic acid decarboxylase with nonradioactive in situ hybridization methods. J Comp Neurol 331:339-362.
27. Esclapez M, Tillakaratne NJ, Kaufman DL, Tobin AJ, Houser CR. 1994. Comparative localization of two form of glutamic acid decarboxylase and their mRNAs in rat brain supports the concept of functional differences between the forms. J Neurosci 14:1834-1855.
28. Gadea A, Lopez-Colome AM. 2001. Glial transporters for glutamate, glycine, and GABA: II. GABA transporters. J Neurosci Res 63:461-468.
29. Gluck MR, Thomas RG, Davis KL, Haroutunian V. 2002. Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients. Am J Psychiatry 159:1165-1173.
30. Gong L, Kostrzewa RM, Li C. 1994. Neonatal 6-hydroxydopamine and adult SKF 38393 treatments alter dopamine D1 receptor mRNA levels: absence of other neurochemical associations with the enhanced behavioral responses of lesioned rats. J Neurochem 63:1282-1290.
31. Greif KF, Erlander MG, Tillakaratne NJ, Tobin AJ. 1991. Postnatal expression of glutamate decarboxylases in developing rat cerebellum. Neurochem Res 16:235-242.
32. Gritti I, Mainville L, Mancia M, Jones BE. 1997. GABAergic and other noncholinergic basal forebrain neurons, together with cholinergic neurons, project to the mesocortex and isocortex in the rat. J Comp Neurol 383:163-177.
33. Hakak Y, Wlaker JR, Li C, Wong WH, Davis KL, Buxbaum JD, Haroutunian V, Fienberg AA. 2001. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 98:4746-4751.
34. Haroutunian V, Perl DP, Purohit DP, Marin DB, Khan K, Lantz M, Davis KL, Mohs RC. 1998. Regional distribution of neuritic plaques in nondemented elderly and cases of very mild Alzheimer's disease. Arch Neurol 55:1185-1191.
35. Harvey PD, Howanitz E, Parrella M, White L, Davidson M, Mohs RC, Hoblyn J, Davis KL. 1998. Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites. Am J Psychiatry 155:1080-1086.
36. Harvey PD, Parrella M, White L, Mohs RC, Davidson M, Davis KL. 1999. Convergence of cognitive and adaptive decline in late-life schizophrenia. Schizophr Res 35:77-84.
37. Healy DJ, Meador-Woodruff JH. 1996. Dopamine receptor gene expression in hippocampus is differentially regulated by the NMDA receptor antagonist MK-801. Eur J Pharmacol 306:257-264.
38. Higuchi R, Fockler C, Dollinger G, Watson R. 1993. Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology 11:1026-1030.
39. Huntsman MM, Tran BV, Potkin SG, Bunney WE Jr, Jones EG. 1998. Altered ratios of alternatively spliced long and short gamma2 subunit mRNAs of the gamma-amino butyrate type A receptor in prefrontal cortex of schizophrenics. Proc Natl Acad Sci USA 95:15066-15071.
40. Kash SF, Tecott LH, Hodge C, Baekkeskov S. 1999. Increased anxiety and altered responses to anxiolytics in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci USA 96:1698-1703.
41. Lewis DA, Pierri JN, Volk DW, Melchitzky DS, Woo TU. 1999. Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia. Biol Psychiatry 46:616-626.
42. Lewis DA, Cruz DA, Melchitzky DS, Pierri JN. 2001. Lamina-specific deficits in parvalbumin-immunoreactive varicosities in the prefrontal cortex of subjects with schizophrenia: evidence for fewer projections from the thalamus. Am J Psychiatry 158:1411-1422.
43. Lidow MS, Song ZM, Castner SA, Allen PB, Greengard P, Goldman-Rakic PS. 2001. Antipsychotic treatment induces alterations in dendrite-and spine-associated proteins in dopamine-rich areas of the primate cerebral cortex. Biol Psychiatry 49:1-12.
44. Marras SA, Kramer FR, Tyagi S. 1999. Multiplex detection of single-nucleotide variations using molecular beacons. Genet Anal 14:151-156.
45. Martin SB, Waniewski RA, Battaglioli G, Martin DL. 2003. Post-mortem degradation of brain glutamate decarboxylase. Neurochem Int 42:549-554.
46. Matsumoto I, Wilce PA, Buckley T, Dodd P, Puzke J, Spanagel R, Zieglgansberger W, Wolf G, Leng S, Rommelspacher H, Finckh U, Schmidt LG. 2001. Ethanol and gene expression in brain. Alcohol Clin Exp Res 25:82S-86S.
47. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L. 1991. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479-486.
48. Park S, Holzman PS. 1992. Schizophrenics show spatial working memory deficits. Arch Gen Psychiatry 49:975-982.
49. Pinal CS, Cortessis V, Tobin AJ. 1997. Multiple elements regulate GAD65 transcription. Dev Neurosci 19:465-475.
50. Purohit DP, Perl DP, Haroutunian V, Powchik P, Davidson M, Davis K. 1998. Alzheimer's disease and related neurodegenerative diseases in elderly schizophrenic patients. Arch Gen Psychiatry 55:205-211.
51. Rajkowska G, Goldman-Rakic PS. 1995. Cytoarchitectonic definition of prefrontal areas in the normal human cortex: 1. Remapping of areas 9 and 46 using quantitative criteria. Cereb Cortex 5:307-322.
52. Reynolds G, Czudek C, Andrews H. 1990. Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia. Biol Psychiatry 27:1038-1044.
53. Ritter LM, Meador-Woodruff JH. 1997. Antipsychotic regulation of hippocampal dopamine receptor messenger RNA expression. Biol Psychiatry 42:155-164.
54. Sheikh SN, Martin SB, Martin DL. 1999. Regional distribution and relative amounts of glutamate decarboxylase isoforms in rat and mouse brain. Neurochem Int 35:73-80.
55. Sherman AD, Davidson AT, Baruah S, Hegwood TS, Waziri R. 1991. Evidence of glutamatergic deficiency in schizophrenia. Neurosci Lett 121:77-80.
56. Simpson MD, Slater P, Deakin JF, Royston MC, Skan WJ. 1989. Reduced GABA uptake sites in the temporal lobe in schizophrenia. Neurosci Lett 107:211-215.
57. Sloviter RS, Dichter MA, Rachinsky TL, Dean E, Goodman JH, Sollas AL, Martin DL. 1996. Basal expression and induction of glutamate decarboxylase and GABA in excitatory granule cells of the rat and monkey hippocampal dentate gyrus. J Comp Neurol 373:593-618.
58. Soghomonian JJ, Martin DL. 1998. Two isoforms of glutamate decarboxylase: why? Trends Pharmacol Sci 19:500-505.
59. Todtenkopf MS, Benes FM. 1998. Distribution of glutamate decarboxylase65 immunoreactive puncta on pyramidal and nonpyramidal neurons in hippocampus of schizophrenic brain. Synapse 29:323-332.
60. Tyagi S, Kramer FR. 1996. Molecular beacons: probes that fluoresce upon hybridization. Nat Biotechnol 14:303-308.
61. Van Bockstaele EJ, Biswas A, Pickel VM. 1993. Topography of serotonin neurons in the dorsal raphe nucleus that send axon collaterals to the rat prefrontal cortex and nucleus accumbens. Brain Res 624:188-198.
62. Vet JA, Majithia AR, Marras SA, Tyagi S, Dube S, Poiesz BJ, Kramer FR. 1999. Multiplex detection of four pathogenic retroviruses using molecular beacons. Proc Natl Acad Sci USA 96:6394-6399.
63. Volk DW, Austin MC, Pierri JN, Sampson AR, Lewis DA. 2000. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry 57:237-245.
64. Volk DW, Austin MC, Pierri JN, Sampson AR, Lewis DA. 2001. GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons. Am J Psychiatry 158:256-265.
65. Woo TU, Whitehead RE, Melchitzky DS, Lewis DA. 1998. A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci USA 95:5341-5346.
66. Yanagawa Y, Kobayashi T, Kamei T, Ishii K, Nishijima M, Takaku A, Tamura S. 1997. Structure and alternative promoters of the mouse glutamic acid decarboxylase 67 gene. Biochem J 326:573-578.